For the FDA, increasing options in clinical research requires the stripping away of informed consent. In his latest newsletter, FDA Commissioner Robert Califf explains: Today, I’d like to catch up with you about another critical component of FDA’s oversight of clinical studies: our work to harmonize clinical research regulations and to facilitate the development of […]
